279 related articles for article (PubMed ID: 32484940)
1. Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppression.
Daley-Yates P; Brealey N; Thomas S; Austin D; Shabbir S; Harrison T; Singh D; Barnes N
Br J Clin Pharmacol; 2021 Feb; 87(2):483-493. PubMed ID: 32484940
[TBL] [Abstract][Full Text] [Related]
2. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
Daley-Yates PT; Deans A; Mehta R; Sousa AR
Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology Versus Convenience: A Benefit/Risk Analysis of Regular Maintenance Versus Infrequent or As-Needed Inhaled Corticosteroid Use in Mild Asthma.
Daley-Yates P; Aggarwal B; Lulic Z; Fulmali S; Cruz AA; Singh D
Adv Ther; 2022 Jan; 39(1):706-726. PubMed ID: 34873657
[TBL] [Abstract][Full Text] [Related]
4. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
Grahnén A; Jansson B; Brundin RM; Ling-Andersson A; Lönnebo A; Johansson M; Eckernäs SA
Eur J Clin Pharmacol; 1997; 52(4):261-7. PubMed ID: 9248762
[TBL] [Abstract][Full Text] [Related]
5. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
Wilson AM; Clark DJ; Devlin MM; McFarlane LC; Lipworth BJ
Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029
[TBL] [Abstract][Full Text] [Related]
6. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
Möllmann H; Wagner M; Krishnaswami S; Dimova H; Tang Y; Falcoz C; Daley-Yates PT; Krieg M; Stöckmann R; Barth J; Lawlor C; Möllmann AC; Derendorf H; Hochhaus G
J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
[TBL] [Abstract][Full Text] [Related]
7. Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.
Bleecker ER; Bateman ED; Busse WW; Woodcock A; Frith L; House KW; Jacques L; Davis AM; Haumann B; Lötvall J
Ann Allergy Asthma Immunol; 2012 Nov; 109(5):353-358.e4. PubMed ID: 23062392
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
Nielsen LP; Dahl R
Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
[TBL] [Abstract][Full Text] [Related]
9. Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma.
Woodcock A; Bleecker ER; Busse WW; Lötvall J; Snowise NG; Frith L; Jacques L; Haumann B; Bateman ED
Respir Res; 2011 Dec; 12(1):160. PubMed ID: 22188590
[TBL] [Abstract][Full Text] [Related]
10. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
Derom E; Van Schoor J; Verhaeghe W; Vincken W; Pauwels R
Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics and pharmacokinetics of fluticasone furoate/vilanterol in healthy Chinese subjects.
Chen X; Zheng X; Jiang J; Hu P; Wu K; Zhuang L; Liu L; Du X; Kempsford R; Allen A
Pharmacotherapy; 2015 Jun; 35(6):586-99. PubMed ID: 26059225
[TBL] [Abstract][Full Text] [Related]
12. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
Clark DJ; Lipworth BJ
Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
[TBL] [Abstract][Full Text] [Related]
13. Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study.
Allen A; Schenkenberger I; Trivedi R; Cole J; Hicks W; Gul N; Jacques L
Clin Respir J; 2013 Oct; 7(4):397-406. PubMed ID: 23578031
[TBL] [Abstract][Full Text] [Related]
14. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Lipworth BJ; Clark DJ; McFarlane LC
Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial.
Adachi M; Goldfrad C; Jacques L; Nishimura Y
Respir Med; 2016 Nov; 120():78-86. PubMed ID: 27817819
[TBL] [Abstract][Full Text] [Related]
16. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
17. Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults.
Wilson AM; Lipworth BJ
Br J Clin Pharmacol; 1999 Oct; 48(4):579-85. PubMed ID: 10583029
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
Ferguson AC; Spier S; Manjra A; Versteegh FG; Mark S; Zhang P
J Pediatr; 1999 Apr; 134(4):422-7. PubMed ID: 10190915
[TBL] [Abstract][Full Text] [Related]
19. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
Derom E; Van De Velde V; Marissens S; Engelstätter R; Vincken W; Pauwels R
Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
Hozawa S; Terada M; Hozawa M
Pulm Pharmacol Ther; 2014 Apr; 27(2):190-6. PubMed ID: 24388868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]